PQA
- 产品代码
- PQA
- 器械名称
- Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System
- 管理类别
- 第 2 类(Class II)
- 21 CFR 条款
- 21 CFR 866.3975
- FDA 专业组
- Microbiology
- 上市路径
- 需提交 510(k) 上市前通告
- 该代码近三年的 510(k)
- 4 件
- 其中 Summary 已存档
- 3 份,可直接下载
- FDA 历史累计 510(k)
- 12 件(全部年份;本站只收录近三年的明细)
FDA 分类定义
A vaginitis and bacterial vaginosis nucleic acid detection system is a qualitative in vitro diagnostic device for the direct detection of nucleic acid sequences from microorganisms associated with vaginitis or bacterial vaginosis. The device is indicated for individuals with signs and symptoms of vaginitis or bacterial vaginosis and aids in the diagnosis of these vaginal infections.
该代码近三年的 510(k)(4 件)
| 510(k) 号 | 批准日期 | 申请人 | 器械名称 | 摘要 |
|---|---|---|---|---|
| K260021 | 2026-07-16 | Roche Molecular Systems, Inc. | cobas® BV/CV | |
| K243725 | 2024-12-19 | Becton, Dickinson and Company | BD Vaginal Panel | FDA |
| K243345 | 2024-11-25 | Hologic, Inc. | Aptima BV Assay; Aptima CV/TV Assay | |
| K231381 | 2023-10-19 | Cepheid | Xpert Xpress MVP; GeneXpert Xpress System |
FDA 官方分类页: PQA
分类与上市路径以 FDA 现行公告为准。本页数据来自 openFDA(CC0 公有领域),不构成注册策略建议。